安徽省阜阳市HIV/HCV共感染者抗病毒治疗服药依从性及影响因素分析 |
| |
引用本文: | 范引光,朱志伟,马炜祥,丁志强,程国金,戴色莺,叶冬青.安徽省阜阳市HIV/HCV共感染者抗病毒治疗服药依从性及影响因素分析[J].中华疾病控制杂志,2017,21(12):1204-1208. |
| |
作者姓名: | 范引光 朱志伟 马炜祥 丁志强 程国金 戴色莺 叶冬青 |
| |
作者单位: | 1. 安徽医科大学公共卫生学院流行病与卫生统计学系, 安徽 合肥 230032; |
| |
基金项目: | 安徽省自然科学基金(1608085MH174);省级质量工程研究项目(2016jxxm0522);国家级大学生创新创业项目(201710366028) |
| |
摘 要: | 目的 探讨安徽省人类免疫缺陷病毒(human immunodeficiency virus,HIV)/丙型肝炎病毒(hepatitis C virus,HCV)共感染者抗病毒治疗服药依从性现状及其影响因素,为制定综合管理策略提供理论依据。方法 采用横断面研究方法,对安徽省阜阳市接受抗病毒治疗1年以上的HIV/HCV共感染者进行问卷调查,收集患者的一般信息和服药情况,采用多因素Logistic回归分析对其服药依从性的影响因素进行分析。结果 256例HIV/HCV共感染者在过去1个月内抗病毒治疗的服药不依从率为34.0%,结婚年限较长(OR=3.049,95%CI:1.435~6.481,P=0.004)、抗病毒治疗时间较长(OR=1.803,95%CI:1.251~2.599,P=0.002)和饮酒者(OR=2.512,95%CI:1.152~5.478,P=0.021)抗病毒治疗依从性较差,而女性(OR=0.180,95%CI:0.089~0.366,P<0.001)和设置服药提醒者(OR=0.315,95%CI:0.159~0.626,P=0.001)的抗病毒治疗依从性较好。结论 降低社会公众的艾滋病歧视和提高HIV/HCV共感染者抗病毒治疗的信心,是改善抗病毒治疗服药依从性的关键。
|
关 键 词: | HIV 获得性免疫缺陷综合征 肝炎病毒 抗病毒药 |
收稿时间: | 2017-06-20 |
Study on influencial factors of adherence to anti-retroviral treatment among people who co-infected with HIV/HCV in Fuyang City,Anhui Province |
| |
Institution: | 1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China;2. Health Station of Jingjiu District, Fuyang City, Fuyang 236000, China;3. AIDS Department of Anhui Provincial Center for Disease Control and Provention, Hefei 230000, China |
| |
Abstract: | Objective To investigate the adherence to anti-retroviral treatment and related factors among human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infectors. Methods In this cross-sectional study, 256 HIV and HCV co-infectors were recruited by convenience sampling method, and information about demography, taking medicine and therapy were collected and analyzed. Results A total of 256 HIV/HCV co-infectors were investigated, 34.0% of them missed dose in the last month. Multiple Logistic regression analysis showed that HIV/HCV co-infectors with long marriage (OR=3.049, 95% CI:1.435-6.481, P=0.004), longer time of treatment with antiretroviral therapy (ART) (OR=1.803, 95% CI:1.251-2.599, P=0.002), frequent alcohol consumption (OR=2.512, 95% CI:1.152-5.478, P=0.021) were risk factors of missed dose, while female (OR=0.180, 95% CI:0.089-0.366, P<0.001) and co-infectors who take a reminder method (OR=0.315, 95% CI:0.159-0.626, P=0.001) were protective factors for missed dose. Conclusions The ART adherence rate of HIV/HCV co-infectors was lower in Anhui Province, comprehensive intervention measures should be taken to promote the ART adherence. |
| |
Keywords: | |
|
| 点击此处可从《中华疾病控制杂志》浏览原始摘要信息 |
| 点击此处可从《中华疾病控制杂志》下载免费的PDF全文 |
|